Andrew O. Yam

568 total citations
17 papers, 433 citations indexed

About

Andrew O. Yam is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Andrew O. Yam has authored 17 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cancer Research. Recurrent topics in Andrew O. Yam's work include Radiopharmaceutical Chemistry and Applications (8 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer, Lipids, and Metabolism (4 papers). Andrew O. Yam is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer, Lipids, and Metabolism (4 papers). Andrew O. Yam collaborates with scholars based in Australia, Canada and New Zealand. Andrew O. Yam's co-authors include Margaret A. Cooley, Stuart A. Rice, Adam Ritchie, Shane T. Grey, Tatyana Chtanova, David Liuwantara, Eliana Mariño, Andy McShea, Andrew Nguyen and Anthony M. Joshua and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Diabetes.

In The Last Decade

Andrew O. Yam

16 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew O. Yam Australia 12 156 132 120 103 64 17 433
Arun Khattri United States 14 169 1.1× 29 0.2× 188 1.6× 77 0.7× 80 1.3× 42 628
Koichi Sawaki Japan 15 120 0.8× 19 0.1× 207 1.7× 93 0.9× 77 1.2× 37 495
Masaki Kuwabara Japan 10 74 0.5× 25 0.2× 117 1.0× 71 0.7× 29 0.5× 23 370
Jianqiang Guo China 11 53 0.3× 34 0.3× 164 1.4× 50 0.5× 35 0.5× 41 356
Mara Beveridge United States 12 44 0.3× 90 0.7× 159 1.3× 80 0.8× 98 1.5× 24 537
Ana Ferreira Portugal 13 84 0.5× 23 0.2× 192 1.6× 156 1.5× 50 0.8× 27 393
Ya Wen Cheng Taiwan 11 38 0.2× 94 0.7× 240 2.0× 23 0.2× 72 1.1× 19 376
Esha Sachdev United States 7 40 0.3× 35 0.3× 144 1.2× 36 0.3× 47 0.7× 9 382
Richard Kirkman United States 11 58 0.4× 26 0.2× 221 1.8× 57 0.6× 46 0.7× 18 379

Countries citing papers authored by Andrew O. Yam

Since Specialization
Citations

This map shows the geographic impact of Andrew O. Yam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew O. Yam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew O. Yam more than expected).

Fields of papers citing papers by Andrew O. Yam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew O. Yam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew O. Yam. The network helps show where Andrew O. Yam may publish in the future.

Co-authorship network of co-authors of Andrew O. Yam

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew O. Yam. A scholar is included among the top collaborators of Andrew O. Yam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew O. Yam. Andrew O. Yam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Crumbaker, Megan, Mitchell G. Lawrence, Leonard D. Goldstein, et al.. (2025). A phase II single arm prospective study of high dose testosterone in combination with carboplatin chemotherapy in late line metastatic castrate-resistant prostate cancer (HIGH-TeCH study).. Journal of Clinical Oncology. 43(5_suppl). 218–218.
2.
Yam, Andrew O., et al.. (2024). Neutrophils under the microscope: neutrophil dynamics in infection, inflammation, and cancer revealed using intravital imaging. Frontiers in Immunology. 15. 1458035–1458035. 3 indexed citations
3.
Yam, Andrew O., Jacqueline Bailey, Scott E. Youlten, et al.. (2023). Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy. Cancer Research. 83(8). 1315–1328. 21 indexed citations
4.
Crumbaker, Megan, Bao Ho, Andrew O. Yam, et al.. (2022). 177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing177Lu-PSMA-I&T Therapy. Journal of Nuclear Medicine. 64(3). 410–415. 39 indexed citations
5.
Crumbaker, Megan, Andrew Nguyen, Andrew O. Yam, et al.. (2022). The Prognostic Value of Posttreatment68Ga-PSMA-11 PET/CT and18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN). Journal of Nuclear Medicine. 64(1). 69–74. 21 indexed citations
6.
Crumbaker, Megan, Bao Ho, Andrew O. Yam, et al.. (2022). Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN). Journal of Nuclear Medicine. 64(2). 221–226. 40 indexed citations
7.
Crumbaker, Megan, Andrew O. Yam, Andrew Nguyen, et al.. (2021). 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial. Journal of Nuclear Medicine. 63(4). 560–566. 31 indexed citations
8.
Crumbaker, Megan, et al.. (2021). A phase I/II study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): Dose escalation results.. Journal of Clinical Oncology. 39(6_suppl). 114–114. 1 indexed citations
9.
10.
Crumbaker, Megan, Andrew O. Yam, Andrew Nguyen, et al.. (2020). Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN). European Urology Oncology. 4(6). 963–970. 31 indexed citations
11.
12.
Yam, Andrew O. & Tatyana Chtanova. (2019). The Ins and Outs of Chemokine-Mediated Immune Cell Trafficking in Skin Cancer. Frontiers in Immunology. 10. 386–386. 11 indexed citations
13.
Yam, Andrew O. & Tatyana Chtanova. (2019). Imaging the neutrophil: Intravital microscopy provides a dynamic view of neutrophil functions in host immunity. Cellular Immunology. 350. 103898–103898. 13 indexed citations
14.
15.
Yam, Andrew O., David Andresen, Alison Kesson, & David Isaacs. (2009). Incidence of sterile cerebrospinal fluid pleocytosis in infants with urinary tract infection. Journal of Paediatrics and Child Health. 45(6). 364–367. 18 indexed citations
16.
Liuwantara, David, et al.. (2006). Nuclear Factor-κB Regulates β-Cell Death. Diabetes. 55(9). 2491–2501. 96 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Khattri Breakdown of academic impact, for papers by Koichi Sawaki Breakdown of academic impact, for papers by Masaki Kuwabara Breakdown of academic impact, for papers by Jianqiang Guo Breakdown of academic impact, for papers by Mara Beveridge Breakdown of academic impact, for papers by Ana Ferreira Breakdown of academic impact, for papers by Ya Wen Cheng Breakdown of academic impact, for papers by Esha Sachdev Breakdown of academic impact, for papers by Richard Kirkman
Rankless by CCL
2026